News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
854,095 Results
Type
Article (86981)
Company Profile (704)
Press Release (766409)
Multimedia
Podcasts (152)
Webinars (19)
Section
Business (232868)
Career Advice (4133)
Deals (39768)
Drug Delivery (130)
Drug Development (91134)
Employer Resources (199)
FDA (18208)
Job Trends (17372)
News (396950)
Policy (39839)
Tag
Academia (3002)
Academic (2)
Accelerated approval (14)
Adcomms (33)
Allergies (109)
Alliances (56977)
ALS (123)
Alzheimer's disease (1613)
Antibody-drug conjugate (ADC) (192)
Approvals (18161)
Artificial intelligence (407)
Autoimmune disease (39)
Automation (20)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (103)
Brain cancer (41)
Breast cancer (407)
Cancer (3201)
Cardiovascular disease (257)
Career advice (3542)
Career pathing (34)
CAR-T (213)
CDC (43)
Cell therapy (588)
Cervical cancer (25)
Clinical research (74476)
Collaboration (1152)
Company closure (3)
Compensation (733)
Complete response letters (38)
COVID-19 (2914)
CRISPR (70)
C-suite (386)
Cystic fibrosis (124)
Data (3247)
Decentralized trials (2)
Denatured (54)
Depression (83)
Diabetes (384)
Diagnostics (6994)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (192)
Drug pricing (156)
Drug shortages (36)
Duchenne muscular dystrophy (160)
Earnings (97795)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131626)
Executive appointments (924)
FDA (20074)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1039)
Gene editing (152)
Generative AI (41)
Gene therapy (463)
GLP-1 (946)
Government (5285)
Grass and pollen (7)
Guidances (215)
Healthcare (20920)
HIV (46)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (194)
Immuno-oncology (13)
Indications (42)
Infectious disease (3119)
Inflammatory bowel disease (166)
Inflation Reduction Act (13)
Influenza (78)
Intellectual property (129)
Interviews (813)
IPO (17907)
IRA (57)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (60)
Layoffs (601)
Leadership (27)
Legal (10138)
Liver cancer (85)
Longevity (12)
Lung cancer (448)
Lymphoma (224)
Machine learning (12)
Management (65)
Manufacturing (478)
MASH (104)
Medical device (14749)
Medtech (14755)
Mergers & acquisitions (22608)
Metabolic disorders (978)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (165)
Neuropsychiatric disorders (47)
Neuroscience (2407)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (497)
Opinion (292)
Ovarian cancer (106)
Pain (128)
Pancreatic cancer (133)
Parkinson's disease (203)
Partnered (25)
Patents (338)
Patient recruitment (186)
Peanut (55)
People (65789)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22975)
Phase II (32336)
Phase III (24358)
Pipeline (1784)
Policy (252)
Postmarket research (3554)
Preclinical (10379)
Press Release (72)
Prostate cancer (156)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (544)
Real estate (7402)
Recruiting (76)
Regulatory (27317)
Reports (62)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (12)
RSV (61)
Schizophrenia (104)
Series A (174)
Series B (120)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4307)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (71)
The Weekly (96)
Vaccines (937)
Venture capital (60)
Weight loss (334)
Women's health (52)
Worklife (20)
Date
Today (153)
Last 7 days (584)
Last 30 days (1991)
Last 365 days (33913)
2025 (19634)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1277)
Alabama (72)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50593)
Australia (8892)
California (8007)
Canada (2483)
China (741)
Colorado (342)
Connecticut (356)
Delaware (215)
Europe (116124)
Florida (1195)
Georgia (274)
Hawaii (3)
Idaho (67)
Illinois (759)
India (34)
Indiana (396)
Iowa (19)
Japan (248)
Kansas (117)
Kentucky (33)
Louisiana (19)
Maine (73)
Maryland (1129)
Massachusetts (6130)
Michigan (280)
Minnesota (500)
Mississippi (4)
Missouri (107)
Montana (32)
Nebraska (26)
Nevada (87)
New Hampshire (74)
New Jersey (2248)
New Mexico (31)
New York (2234)
North Carolina (1267)
North Dakota (10)
Northern California (3475)
Ohio (259)
Oklahoma (17)
Oregon (48)
Pennsylvania (1714)
Puerto Rico (18)
Rhode Island (40)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2978)
Tennessee (132)
Texas (1238)
United States (30208)
Utah (233)
Virginia (220)
Washington D.C. (80)
Washington State (704)
West Virginia (4)
Wisconsin (87)
There are 854,095 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Regenerex Pharma, Inc. Enters Into Licensing Agreement with Holista Colltech Ltd.
July 31, 2025
·
3 min read
Press Releases
Hemostemix Increases Previously Closed Private Placement to $3,000,000
July 31, 2025
·
9 min read
Press Releases
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
July 31, 2025
·
1 min read
Press Releases
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 31, 2025
·
1 min read
Press Releases
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025
July 31, 2025
·
1 min read
Press Releases
Ultragenyx Completes Enrollment of Phase 3 Aspire Study Evaluating GTX-102 for the Treatment of Angelman Syndrome
July 31, 2025
·
7 min read
Press Releases
LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia
July 31, 2025
·
8 min read
Press Releases
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2025 Financial Results on August 7, 2025
July 31, 2025
·
1 min read
Press Releases
Ascendis Pharma to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
July 31, 2025
·
3 min read
Press Releases
AMGEN ANNOUNCES WEBCAST OF 2025 SECOND QUARTER FINANCIAL RESULTS
July 31, 2025
·
2 min read
1 of 85,410
Next